<DOC>
	<DOCNO>NCT02063906</DOCNO>
	<brief_summary>Recently , investigator face `` edge '' treatment decision decide adjuvant systemic treatment , especially patient show discordance stage tumor biology . The aim study compare prognostic relevance TNM stag system intrinsic subtype breast cancer patient receive curative surgery .</brief_summary>
	<brief_title>Prognostic Relevance Biological Subtype Breast Cancer</brief_title>
	<detailed_description>Identified patient receive curative surgery stage I-III breast cancer available data immunohistochemistry profile include hormone receptor status ( HR ) status , human epidermal growth factor receptor 2 ( HER2 ) status , Ki 67 stain Samsung Medical Center January 2004 September 2008 . Primary outcomes recurrence-free survival ( RFS ) overall survival ( OS ) .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>patient receive curative surgery stage IIII breast cancer January 2004 September 2008 available immunohistochemistry profile . exclusion Criteria : age &lt; 18 year old microinvasive carcinoma breast</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2014</verification_date>
</DOC>